Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL)

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 1033-1039

  Puente Navazo, Marta D ^a   Daviet, Laurent ^a   Ninio, Ewa ^b   McGregor, John L ^a,c  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Division of Hematology   (United States)

Author keywords

CD36; foam cell formation; oxidized LDL

Indexed keywords

CD36 ANTIGEN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; FOAM CELL; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0010875433     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.atv.16.8.1033     Document Type: Article

References (33)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1990;62:801-809.
2. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL-related protein (LRP). Annu Rev Biochem. 1994;62:601-637.
3. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem. 1994;269:21006-21009.
4. Endemann G, Stanton LMW, Madden KS, Bryant C, White TW, Protter AA. CD36 is a receptor for oxidized low density lipoproteins. J Biol Chem. 1993;268:11811-11816.
5. Nicholson AC, Frieda S, Pearce FA, Silverstein RL. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines: evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol. 1995;15:269-275.
6. Nozaki S, Yamashita S, Kashiwagi H, Tomiyama Y, Nakata A, Nakagawa T, Ishigami J, Miyagawa J, Takemura K, Kurata Y, Matsuzawa Y. The role of CD36 on foam cell formation: reduced uptake of oxidized LDL in monocyte-derived macrophages from CD36-deficient patients. Circulation. 1994;90(pt 2):I-190. Abstract.
7. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine. Blood. 1992;80:656-664.
8. Tandon NN, Kralisz U, Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem. 1989;264:7576-7583.
9. Asch AS, Barnwell J, Silverstein RL, Nachman RL. Isolation of the thrombospondin membrane receptor. J Clin Invest. 1987;79:1054-1061.
10. Silverstein RL, Asch AS, Nachman RL. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest. 1989;84:546-552.
11. Oquendo P, Hundt E, Lawyler J, Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum-parasitized erythrocytes. Cell. 1989;58:95-101.
12. Schuepp BJ, Pfister H, Clemetson KJ, Silverstein RL, Jungi TW. CD36-mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognizing cell membrane-bound thrombospondin. Biochem Biophys Res Commun. 1991;175:263-270.
13. Ockenhouse CF, Magowan C, Chulay JD. Activation of monocytes and platelets by monoclonal antibodies or malaria-infecTedted erythrocytes binding to the CD36 surface receptor in vitro, J Clin Invest. 1989;84:468-475.
14. Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci U S A. 1991;88:7844-7848.
15. Huh HY, Lo JS, Yesner IM, Silverstein RL. CD36 induction on human monocytes upon adhesion to tumor necrosis factor activated endothelial cells. J Biol Chem. 1995;270:6267-6271.
16. Savill JS, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest. 1992;90:1513-1522.
17. Daviet L, Craig AG, McGregor L, Reck M-P, Wild TF, Berendt AR, Newbold CI, McGregor JL. An immunodominant domain (155-183) on human CD36 plays an important role in platelet functions and malarial cytoadherence. Thromb Haemost. 1995;73:1141. Abstract.
18. Parmentier S, McGregor L, Catimel B, Leung LL, McGregor JL. Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein. Blood. 1991;77:1734-1739.
19. Daviet L, Buckland R, Puente Navazo MD, McGregor JL. Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue replacement mutagenesis. Biochem J. 1995;303:221-224.
20. Chapman MJ, Laplaud PM, Luc G, Forgez O, Bruckert E, Goulinet S, Lagrange D. Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient centrifugation. J Lipid Res. 1988;29:442-458.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
22. Noble JA. Electrophoretic separation of plasma lipoproteins in agarose-gel. J Lipid Res. 1968;9:663-670.
23. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1976;30:302-310.
24. el-Saadani MH, Esterbauer H, el-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 1989;30:627-630.
25. Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D. Human neutrophils lose their surface Fc γRIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 1995;85:532-540.
26. a antibodies. Thromb Haemost. 1995;73:543-545.
27. Leung LLK, Li W-X, McGregor JL, Albrecht G, Howard RJ. CD36 peptides enhance or inhibit CD36 thrombospondin binding. J Biol Chem. 1992;267:18244-18250.
28. Greenwalt DE, Scheck SH, Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest. 1995;96:1382-1388.
29. Asch AS, Liu I, Briccetti JW, Barnwell FM, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M. Analysis of CD36 binding domains/ligand specificity controlled by dephosphorylation of an ectodomain. Science. 1993;262:1436-1440.
30. Pearce SFA, Wu J, Silverstein RL. Recombinant GST/CD36 fusion proteins define a thrombospondin binding site. J Biol Chem. 1995;270:2981-2986.
31. Aiken ML, Ginsberg MH, Byers-Wardard V, Plow EF. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood. 1990;76:2501-2509.
32. Puente Navazo MD, Daviet L, Ren Y, Leung LLK, McGregor JL. Structural/functional characterization of a functional domain on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem. In press.
33. Armesilla AL, Vega MA. Structural organization of the gene for human CD36 glycoprotein. J Biol Chem. 1994;269:18985-18991.